Ronald Hoffman; Bruce Furie; Philip McGlave; Leslie E. Silberstein; Sanford J. Shattil; Edward J. Benz; Helen Heslop Churchill Livingstone (2008) Kovakantinen kirja
Ronald Hoffman; Edward J. Benz; Leslie E. Silberstein; Helen Heslop; Bruce Furie; Philip McGlave; Sanford J. Shattil Churchill Livingstone (2008) Kovakantinen kirja
M. F. Atiyah; C.T. Taam; J. Eells; K. M. Hoffman; L. Hörmander; C. E. Rickart; H. Rossi; S. Smale; F. Treves; J Wermer Springer-Verlag Berlin and Heidelberg GmbH & Co. KG (1969) Pehmeäkantinen kirja
Taylor & Francis Inc Sivumäärä: 476 sivua Asu: Kovakantinen kirja Painos: 2nd edition Julkaisuvuosi: 2007, 25.06.2007 (lisätietoa) Kieli: Englanti
The world of medicine has become splintered into two factions, that of orthodoxy and its counterpart, alternative or complementary medicine. A problem with alternative medicine is, of course, that of anecdote and hearsay. The solution: the disclosure, in an unassailable fashion, of the underlying biochemical principles for alternative cancer therapies.
Cancer and the Search for Selective Biochemical Inhibitors, Second Edition delineates the underlying biochemical principles for alternative cancer therapies. Completely revised and updated, this edition includes coverage of the link between concepts and practices of alternative and conventional medicine. The author examines anticancer plant substances and other alternatives such as Vitamin C, essiac tea, shark cartilage, and cat’s claw. The text also addresses the problem of determining selective and non-toxic enzyme inhibitors for cancer cell metabolic pathways.
While an increased number of allopathic professionals are in tune with alternative therapies, the integration of the two factions is far from the norm. Keeping the same format that made its predecessor a benchmark text, this book compares complementary, alternative, and integrative treatments with chemotherapy and other more traditional treatments.